03:11:36 EDT Tue 30 Apr 2024
Enter Symbol
or Name
USA
CA



V:RX - BioSyent Inc. - http://www.biosyent.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
RX - V  13.18.50·8.630.38.50-0.01-0.121.0177548.50  8.63  8.439.26  7.03Apr 29Apr 2515 min RT 2¢
TSX-V - V13.18.50·8.630.38.63+0.121.416.2137288.50  8.63  8.439.26  7.03Apr 2915 min
NEO ATS - U 8.50-0.01-0.11.0868.50  8.50  8.50Apr 2915 min
Omega - O 8.50-0.01-0.10.7638.50  8.54  8.50Apr 2915 min
Pure - P 8.510.1011    15 min
Chi-X - X 8.50-0.01-0.10.5438.49  8.50  8.49Apr 2915 min
CX2 - H 8.50-0.01-0.11.71478.51  8.51  8.50Apr 2915 min
TriAct - M 8.510.876    Sep 11-2015 min

Recent Trades - Last 10 of 54
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:04:15M8.630.12180 National Bank80 National BankE
14:00:38P8.50-0.01957 TD Sec79 CIBCE
14:00:38H8.50-0.011007 TD Sec79 CIBCK
14:00:38H8.50-0.015001 Anonymous79 CIBCK
12:48:51V8.630.1220076 iA76 iAK
11:07:27O8.50-0.014001 Anonymous1 AnonymousK
11:07:27H8.50-0.0130079 CIBC1 AnonymousK
11:07:27X8.50-0.013009 BMO Nesbitt2 RBCK
11:07:27V8.50-0.014009 BMO Nesbitt2 RBCK
11:07:27U8.50-0.011009 BMO Nesbitt2 RBCK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-04-25 10:13C:RX8.40SEDAR Annual ReportSEDAR Annual Report
2024-04-15 16:50C:RX8.64News ReleaseBioSyent extends licence for RepaGyn, Proktis-M
2024-03-27 18:38C:RX8.70News ReleaseBioSyent grants 66,020 RSUs
2024-03-13 17:47C:RX8.65SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-03-13 17:47C:RX8.65SEDAR MD & ASEDAR MD & A
2024-03-13 17:41C:RX8.65News ReleaseBioSyent earns $6.46-million in 2023
2024-03-06 16:37C:RX8.65News ReleaseBioSyent to release fiscal 2023 results March 13
2024-02-06 16:35C:RX8.75News ReleaseBioSyent increases quarterly dividend to 4.5 cents
2024-02-06 16:11C:RX8.60Dividend DeclaredBioSyent to pay 4.5-cent dividend
2023-12-13 16:12C:RX8.62Normal Course Issuer BidBioSyent normal course issuer bid
2023-12-13 11:47C:RX8.62News ReleaseBioSyent may buy back up to 650,000 shares under NCIB
2023-11-20 11:02C:RX8.30News ReleaseBioSyent begins shipping Gelclair to Canada
2023-11-16 10:23C:RX8.00News ReleaseBioSyent earns $2.35-million in Q3 2023
2023-11-16 08:13C:RX8.00SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-16 08:12C:RX8.00SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-15 16:39C:RX8.00News ReleaseBioSyent to pay four-cent dividend Dec. 15
2023-11-09 13:57C:RX8.00News ReleaseBioSyent to release Q3 results Nov. 16
2023-10-18 11:42C:RX8.00News ReleaseBioSyent rolls out menopauseinformation website
2023-08-22 16:44C:RX7.60SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-22 16:41C:RX7.60SEDAR Interim MD & ASEDAR Interim MD & A